Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes

Annals of the New York Academy of Sciences

Volumn 1388, Issue 1, 2017, Pages 42-58

  Adu Oppong, Boahemaa ^a   Gasparrini, Andrew J ^a   Dantas, Gautam ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

antimicrobial resistance; antimicrobials; metagenomics; microbiome

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG SYNTHESIS; GENETIC DATABASE; HISTORY OF MEDICINE; HUMAN; HYBRIDIZATION; METAGENOMICS; MICROBIAL ACTIVITY; MICROBIAL DIVERSITY; MICROBIAL GENOME; MICROBIOME; NONHUMAN; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; DRUG RESISTANCE; GENETICS; GENOMICS; MICROFLORA; PROCEDURES;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE; GENOMICS; MICROBIOTA;

EID: 84992349858     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13257     Document Type: Article

References (152)

1. Lederberg, J. & A.T. McCray. 2001. ‘Ome sweet’ omics—a genealogical treasury of words. The Scientist. 15: 8.
2. Turnbaugh, P.J., R.E. Ley, M. Hamady, et al. 2007. The human microbiome project. Nature 449: 804–810.
3. Allen, H.K., J. Donato, H.H. Wang, et al. 2010. Call of the wild: antibiotic resistance genes in natural environments. Nat. Rev. Microbiol. 8: 251–259.
4. Sender, R., S. Fuchs & R. Milo. 2016. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164: 337–340.
5. Ursell, L.K., J.L. Metcalf, L.W. Parfrey, et al. 2012. Defining the human microbiome. Nutr. Rev. 70(Suppl. 1): S38–S44.
6. Roesch, L.F.W., R.R. Fulthorpe, A. Riva, et al. 2007. Pyrosequencing enumerates and contrasts soil microbial diversity. ISME J. 1: 283–290.
7. Waldor, M.K., G. Tyson, E. Borenstein, et al. 2015. Where next for microbiome research? PLoS Biol. 13: e1002050.
8. Donia, M.S., P. Cimermancic, C.J. Schulze, et al. 2014. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158: 1402–1414.
9. Sommer, M.O., G.M. Church & G. Dantas. 2010. The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence 1: 299–303.
10. Perry, J.A., E.L. Westman & G.D. Wright. 2014. The antibiotic resistome: what's new? Curr. Opin. Microbiol. 21: 45–50.
11. Sommer, M.O. & G. Dantas. 2011. Antibiotics and the resistant microbiome. Curr. Opin. Microbiol. 14: 556–563.
12. D'Costa, V.M., K.M. McGrann, D.W. Hughes, et al. 2006. Sampling the antibiotic resistome. Science 311: 374–377.
13. Wright, G.D. 2007. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 5: 175–186.
14. O'Neill, J. 2016. Securing new drugs for future generations: the pipeline of antibiotics. Accesssed August 22, 2016. http://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf.
15. Walsh, C.T. & T.A. Wencewicz. 2014. Prospects for new antibiotics: a molecule-centered perspective. J. Antibiot. (Tokyo) 67: 7–22.
16. Lewis, K. 2013. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12: 371–387.
17. Knapp, C.W., J. Dolfing, P.A. Ehlert, et al. 2010. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ. Sci. Technol. 44: 580–587.
18. Centers for Disease Control and Prevention, 2013. Antibiotic resistance threats in the United States. Accessed August 22, 2016. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
19. Cooper, M.A. & D. Shlaes. 2011. Fix the antibiotics pipeline. Nature 472: 32.
20. Roberts, R.R., B. Hota, I. Ahmad, et al. 2009. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin. Infect. Dis. 49: 1175–1184.
21. O'Neill, J. 2016. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance.
22. Fischbach, M.A. & C.T. Walsh. 2009. Antibiotics for emerging pathogens. Science 325: 1089–1093.
23. Kinch, M.S., E. Patridge, M. Plummer, et al. 2014. An analysis of FDA-approved drugs for infectious disease: antibacterial agents. Drug Discov. Today 19: 1283–1287.
24. Howard, D.H. & R.D. Scott. 2005. The economic burden of drug resistance. Clin. Infect. Dis. 41: S283–S286.
25. Miller, A. 2016. Antibacterial development: a changing landscape. Microbe Magazine. Accessed August 22, 2016. http://www.asmscience.org/content/journal/microbe/10.1128/microbe.11.111.1.
26. Tenover, F.C. 2006. Mechanisms of antimicrobial resistance in bacteria. Am. J. Infect. Control. 34: S3–S10; discussion S64–S73.
27. Walsh, C. 2000. Molecular mechanisms that confer antibacterial drug resistance. Nature 406: 775–781.
28. Alekshun, M.N. & S.B. Levy. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128: 1037–1050.
29. MacLean, R.C., A.R. Hall, G.G. Perron, et al. 2010. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat. Rev. Genet. 11: 405–414.
30. Baltz, R.H. 2010. Genomics and the ancient origins of the daptomycin biosynthetic gene cluster. J. Antibiot. (Tokyo) 63: 506–511.
31. Fajardo, A. & J.L. Martinez. 2008. Antibiotics as signals that trigger specific bacterial responses. Curr. Opin. Microbiol. 11: 161–167.
32. Clardy, J., M.A. Fischbach & C.R. Currie. 2009. The natural history of antibiotics. Curr. Biol. 19: R437–R441.
33. Nelson, M.L., A. Dinardo, J. Hochberg, et al. 2010. Brief communication: mass spectroscopic characterization of tetracycline in the skeletal remains of an ancient population from Sudanese Nubia 350–550 CE. Am. J. Phys. Anthropol. 143: 151–154.
34. Bassett, E.J., M.S. Keith, G.J. Armelagos, et al. 1980. Tetracycline-labeled human bone from ancient Sudanese Nubia (A.D. 350). Science 209: 1532–1534.
35. Aminov, R.I. 2010. A brief history of the antibiotic era: lessons learned and challenges for the future. Front. Microbiol. 1: 134.
36. Jones, D.S., S.H. Podolsky & J.A. Greene. 2012. The burden of disease and the changing task of medicine. N. Engl. J. Med. 366: 2333–2338.
37. Elsner, H.L. 1910. The new treatment of syphilis (ehrlich-hata): observations and results. J. Am. Med. Assoc. 55: 2052–2057.
38. Fleming, A. 2001. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929. Bull. World Health Organ. 79: 780–790.
39. Schatz, A., E. Bugie & S.A. Waksman. 1944. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Clin. Orthop. Relat. Res. 55: 66–69.
40. Zetterstrom, R. 2007. Selman A. Waksman (1888–1973) Nobel Prize in 1952 for the discovery of streptomycin, the first antibiotic effective against tuberculosis. Acta Paediatr. 96: 317–319.
41. Brown, E.D. & G.D. Wright. 2016. Antibacterial drug discovery in the resistance era. Nature 529: 336–343.
42. Pelaez, F. 2006. The historical delivery of antibiotics from microbial natural products—can history repeat? Biochem. Pharmacol. 71: 981–990.
43. Fernandes, P. 2006. Antibacterial discovery and development—the failure of success? Nat. Biotechnol. 24: 1497–1503.
44. Zaffiri, L., J. Gardner & L.H. Toledo-Pereyra. 2012. History of antibiotics. From salvarsan to cephalosporins. J. Invest. Surg. 25: 67–77.
45. Walsh, C. 2003. Antibiotics: Actions, Origins, Resistance. Washington, DC: ASM Press.
46. Davies, J. & D. Davies. 2010. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74: 417–433.
47. de la Cruz, F. & J. Davies. 2000. Horizontal gene transfer and the origin of species: lessons from bacteria. Trends Microbiol. 8: 128–133.
48. Blair, J.M., M.A. Webber, A.J. Baylay, et al. 2015. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13: 42–51.
49. Roberts, M.C. 1996. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol. Rev. 19: 1–24.
50. Ogawa, W., M. Onishi, R. Ni, et al. 2012. Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae. Gene 498: 177–182.
51. Ruggerone, P., S. Murakami, K.M. Pos, et al. 2013. RND efflux pumps: structural information translated into function and inhibition mechanisms. Curr. Top. Med. Chem. 13: 3079–3100.
52. Hinchliffe, P., M.F. Symmons, C. Hughes, et al. 2013. Structure and operation of bacterial tripartite pumps. Annu. Rev. Microbiol. 67: 221–242.
53. Piddock, L.J. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19: 382–402.
54. Tamber, S. & R.E. Hancock. 2003. On the mechanism of solute uptake in Pseudomonas. Front. Biosci. 8: s472–s483.
55. Poulou, A., E. Voulgari, G. Vrioni, et al. 2013. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. J. Clin. Microbiol. 51: 3176–3182.
56. Katayama, Y., T. Ito & K. Hiramatsu. 2000. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 44: 1549–1555.
57. Neu, H.C. 1969. Effect of β-lactamase location in Escherichia coli on penicillin synergy. Appl. Microbiol. 17: 783–786.
58. Bush, K. 2010. Bench-to-bedside review: the role of β-lactamases in antibiotic-resistant Gram-negative infections. Crit. Care 14: 224.
59. Yang, W., I.F. Moore, K.P. Koteva, et al. 2004. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J. Biol. Chem. 279: 52346–52352.
60. Forsberg, K.J., S. Patel, T.A. Wencewicz, et al. 2015. The tetracycline destructases: a novel family of tetracycline-inactivating enzymes. Chem. Biol. 22: 888–897.
61. Shaw, W.V., L.C. Packman, B.D. Burleigh, et al. 1979. Primary structure of a chloramphenicol acetyltransferase specified by R plasmids. Nature 282: 870–872.
62. D'Costa, V.M., C.E. King, L. Kalan, et al. 2011. Antibiotic resistance is ancient. Nature 477: 457–461.
63. Bhullar, K., N. Waglechner, A. Pawlowski, et al. 2012. Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS One 7: e34953.
64. Palmer, A.C., E. Angelino & R. Kishony. 2010. Chemical decay of an antibiotic inverts selection for resistance. Nat. Chem. Biol. 6: 105–107.
65. Martinez, J.L. 2012. Natural antibiotic resistance and contamination by antibiotic resistance determinants: the two ages in the evolution of resistance to antimicrobials. Front. Microbiol. 3: 1.
66. Abraham, E.P. & E. Chain. 1988. An enzyme from bacteria able to destroy penicillin. 1940. Rev. Infect. Dis. 10: 677–678.
67. Hall, B.G., S.J. Salipante & M. Barlow. 2004. Independent origins of subgroup Bl + B2 and subgroup B3 metallo-beta-lactamases. J. Mol. Evol. 59: 133–141.
68. Hall, B.G. & M. Barlow. 2004. Evolution of the serine beta-lactamases: past, present and future. Drug Resist. Updat. 7: 111–123.
69. Stokes, H.W. & M.R. Gillings. 2011. Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiol. Rev. 35: 790–819.
70. Gould, S.J. & E.S. Vrba. 1982. Exaptation—a missing term in the science of form. Paleobiology 8: 4–15.
71. Sommer, M.O., G. Dantas & G.M. Church. 2009. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325: 1128–1131.
72. Forsberg, K.J., A. Reyes, B. Wang, et al. 2012. The shared antibiotic resistome of soil bacteria and human pathogens. Science 337: 1107–1111.
73. D'Costa, V.M., E. Griffiths & G.D. Wright. 2007. Expanding the soil antibiotic resistome: exploring environmental diversity. Curr. Opin. Microbiol. 10: 481–489.
74. Didelot, X., R. Bowden, D.J. Wilson, et al. 2012. Transforming clinical microbiology with bacterial genome sequencing. Nat. Rev. Genet. 13: 601–612.
75. Kwong, J.C., N. McCallum, V. Sintchenko, et al. 2015. Whole genome sequencing in clinical and public health microbiology. Pathology 47: 199–210.
76. Koser, C.U., J.M. Bryant, J. Becq, et al. 2013. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N. Engl. J. Med. 369: 290–292.
77. Li, L., N. Mendis, H. Trigui, et al. 2014. The importance of the viable but non-culturable state in human bacterial pathogens. Front. Microbiol. 5: 258.
78. Ma, L., J. Kim, R. Hatzenpichler, et al. 2014. Gene-targeted microfluidic cultivation validated by isolation of a gut bacterium listed in Human Microbiome Project's Most Wanted taxa. Proc. Natl. Acad. Sci. U.S.A. 111: 9768–9773.
79. Nichols, D., N. Cahoon, E.M. Trakhtenberg, et al. 2010. Use of ichip for high-throughput in situ cultivation of “uncultivable” microbial species. Appl. Environ. Microbiol. 76: 2445–2450.
80. Kaeberlein, T., K. Lewis & S.S. Epstein. 2002. Isolating “uncultivable” microorganisms in pure culture in a simulated natural environment. Science 296: 1127–1129.
81. Lagier, J.C., F. Armougom, M. Million, et al. 2012. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin. Microbiol. Infect. 18: 1185–1193.
82. McLain, J.E., E. Cytryn, L.M. Durso, et al. 2016. Culture-based methods for detection of antibiotic resistance in agroecosystems: advantages, challenges, and gaps in knowledge. J. Environ. Qual. 45: 432–440.
83. Wetterstrand, K.A. DNA sequencing costs: data from the NHGRI Genome Sequencing Program (GSP). Accessed August 22, 2016. www.genome.gov/sequencingcostsdata.
84. Pettersson, E., J. Lundeberg & A. Ahmadian. 2009. Generations of sequencing technologies. Genomics 93: 105–111.
85. Bonetta, L. 2010. Whole-genome sequencing breaks the cost barrier. Cell 141: 917–919.
86. Niedringhaus, T.P., D. Milanova, M.B. Kerby, et al. 2011. Landscape of next-generation sequencing technologies. Anal. Chem. 83: 4327–4341.
87. Christensen, K.D., D. Dukhovny, U. Siebert, et al. 2015. Assessing the costs and cost-effectiveness of genomic sequencing. J. Pers. Med. 5: 470–486.
88. Mardis, E.R. 2008. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 9: 387–402.
89. Koboldt, D.C., K.M. Steinberg, D.E. Larson, et al. 2013. The next-generation sequencing revolution and its impact on genomics. Cell 155: 27–38.
90. Pehrsson, E.C., K.J. Forsberg, M.K. Gibson, et al. 2013. Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs. Front. Microbiol. 4: 145.
91. Allen, H.K., L.A. Moe, J. Rodbumrer, et al. 2009. Functional metagenomics reveals diverse β-lactamases in a remote Alaskan soil. ISME J. 3: 243–251.
92. Moore, A.M., S. Patel, K.J. Forsberg, et al. 2013. Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS One 8: e78822.
93. Moore, A.M., C. Munck, M.O. Sommer, et al. 2011. Functional metagenomic investigations of the human intestinal microbiota. Front. Microbiol. 2: 188.
94. Perron, G.G., L. Whyte, P.J. Turnbaugh, et al. 2015. Functional characterization of bacteria isolated from ancient arctic soil exposes diverse resistance mechanisms to modern antibiotics. PLoS One 10: e0069533.
95. Clemente, J.C., E.C. Pehrsson, M.J. Blaser, et al. 2015. The microbiome of uncontacted Amerindians. Sci. Adv. 1. pii: e1500183.
96. Pehrsson, E.C., P. Tsukayama, S. Patel, et al. 2016. Interconnected microbiomes and resistomes in low-income human habitats. Nature 533: 212–216.
97. Lam, K.N., J. Cheng, K. Engel, et al. 2015. Current and future resources for functional metagenomics. Front. Microbiol. 6: 1196.
98. Schmieder, R. & R. Edwards. 2012. Insights into antibiotic resistance through metagenomic approaches. Future Microbiol. 7: 73–89.
99. Forsberg, K.J., S. Patel, M.K. Gibson, et al. 2014. Bacterial phylogeny structures soil resistomes across habitats. Nature 509: 612–616.
100. Mezger, A., E. Gullberg, J. Goransson, et al. 2015. A general method for rapid determination of antibiotic susceptibility and species in bacterial infections. J. Clin. Microbiol. 53: 425–432.
101. Gibson, M.K., B. Wang, S. Ahmadi, et al. 2016. Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome. Nat. Microbiol. 1: 16024.
102. Buelow, E., T.B. Gonzalez, D. Versluis, et al. 2014. Effects of selective digestive decontamination (SDD) on the gut resistome. J. Antimicrob. Chemother. 69: 2215–2223.
103. Bengtsson-Palme, J., F. Boulund, J. Fick, et al. 2014. Shotgun metagenomics reveals a wide array of antibiotic resistance genes and mobile elements in a polluted lake in India. Front. Microbiol. 5: 648.
104. Meyer, F., D. Paarmann, M. D'Souza, et al. 2008. The metagenomics RAST server—a public resource for the automatic phylogenetic and functional analysis of metagenomes. BMC Bioinformatics 9: 386.
105. Segata, N., L. Waldron, A. Ballarini, et al. 2012. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 9: 811–814.
106. Altschul, S.F., W. Gish, W. Miller, et al. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403–410.
107. Hu, Y., X. Yang, J. Qin, et al. 2013. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 4: 2151.
108. Forslund, K., S. Sunagawa, J.R. Kultima, et al. 2013. Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 23: 1163–1169.
109. Durso, L.M., G.P. Harhay, J.L. Bono, et al. 2011. Virulence-associated and antibiotic resistance genes of microbial populations in cattle feces analyzed using a metagenomic approach. J. Microbiol. Methods 84: 278–282.
110. Ma, L., B. Li & T. Zhang. 2014. Abundant rifampin resistance genes and significant correlations of antibiotic resistance genes and plasmids in various environments revealed by metagenomic analysis. Appl. Microbiol. Biotechnol. 98: 5195–5204.
111. Abeles, S.R., M. Ly, T.M. Santiago-Rodriguez, et al. 2015. Effects of long term antibiotic therapy on human oral and fecal viromes. PLoS One 10: e0134941.
112. Gibson, M.K., K.J. Forsberg & G. Dantas. 2015. Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology. ISME J. 9: 207–216.
113. Xavier, B.B., A.J. Das, G. Cochrane, et al. 2016. Consolidating and exploring antibiotic resistance gene data resources. J. Clin. Microbiol. 54: 851–859.
114. Liu, B. & M. Pop. 2009. ARDB—antibiotic resistance genes database. Nucleic Acids Res. 37: D443–D447.
115. Looft, T., T.A. Johnson, H.K. Allen, et al. 2012. In-feed antibiotic effects on the swine intestinal microbiome. Proc. Natl. Acad. Sci. U.S.A. 109: 1691–1696.
116. Nesme, J., S. Cecillon, T.O. Delmont, et al. 2014. Large-scale metagenomic-based study of antibiotic resistance in the environment. Curr. Biol. 24: 1096–1100.
117. Modi, S.R., H.H. Lee, C.S. Spina, et al. 2013. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499: 219–222.
118. Smillie, C.S., M.B. Smith, J. Friedman, et al. 2011. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480: 241–244.
119. McArthur, A.G., N. Waglechner, F. Nizam, et al. 2013. The comprehensive antibiotic resistance database. Antimicrob. Agents Chemother. 57: 3348–3357.
120. Gupta, S.K., B.R. Padmanabhan, S.M. Diene, et al. 2014. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob. Agents Chemother. 58: 212–220.
121. Yamashita, A., T. Sekizuka & M. Kuroda. 2014. Characterization of antimicrobial resistance dissemination across plasmid communities classified by network analysis. Pathogens 3: 356–376.
122. McCall, C.A., E. Bent, T.S. Jorgensen, et al. 2016. Metagenomic comparison of antibiotic resistance genes associated with liquid and dewatered biosolids. J. Environ. Qual. 45: 463–470.
123. Thai, Q.K., F. Bos & J. Pleiss. 2009. The Lactamase Engineering Database: a critical survey of TEM sequences in public databases. BMC Genomics 10: 390.
124. Fischer, M., Q.K. Thai, M. Grieb, et al. 2006. DWARF—a data warehouse system for analyzing protein families. BMC Bioinformatics 7: 495.
125. Tsafnat, G., J. Copty & S.R. Partridge. 2011. RAC: repository of antibiotic resistance cassettes. Database (Oxford) 2011: bar054.
126. Zankari, E., H. Hasman, S. Cosentino, et al. 2012. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67: 2640–2644.
127. McArthur, A.G. & G.D. Wright. 2015. Bioinformatics of antimicrobial resistance in the age of molecular epidemiology. Curr. Opin. Microbiol. 27: 45–50.
128. Lim, H.K., E.J. Chung, J.C. Kim, et al. 2005. Characterization of a forest soil metagenome clone that confers indirubin and indigo production on Escherichia coli. Appl. Environ. Microbiol. 71: 7768–7777.
129. Brady, S.F. & J. Clardy. 2000. Long-chain N-acyl amino acid antibiotics isolated from heterologously expressed environmental DNA. J. Am. Chem. Soc. 122: 12903–12904.
130. Banik, J.J. & S.F. Brady. 2010. Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules. Curr. Opin. Microbiol. 13: 603–609.
131. Katz, M., B.M. Hover & S.F. Brady. 2016. Culture-independent discovery of natural products from soil metagenomes. J. Ind. Microbiol. Biotechnol. 43: 129–141.
132. Stevens, D.C., K.R. Conway, N. Pearce, et al. 2013. Alternative sigma factor over-expression enables heterologous expression of a type II polyketide biosynthetic pathway in Escherichia coli. PLoS One 8: e64858.
133. McMahon, M.D., C. Guan, J. Handelsman, et al. 2012. Metagenomic analysis of Streptomyces lividans reveals host-dependent functional expression. Appl. Environ. Microbiol. 78: 3622–3629.
134. Lee, M.H. & S.W. Lee. 2013. Bioprospecting potential of the soil metagenome: novel enzymes and bioactivities. Genomics Inform. 11: 114–120.
135. Ling, L.L., T. Schneider, A.J. Peoples, et al. 2015. A new antibiotic kills pathogens without detectable resistance. Nature 517: 455–459.
136. Seow, K.T., G. Meurer, M. Gerlitz, et al. 1997. A study of iterative type II polyketide synthases, using bacterial genes cloned from soil DNA: a means to access and use genes from uncultured microorganisms. J. Bacteriol. 179: 7360–7368.
137. Weber, T., K. Blin, S. Duddela, et al. 2015. AntiSMASH 3.0—a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 43: W237–W243.
138. Cimermancic, P., M.H. Medema, J. Claesen, et al. 2014. Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell 158: 412–421.
139. Raveh-Sadka, T., B.C. Thomas, A. Singh, et al. 2015. Gut bacteria are rarely shared by co-hospitalized premature infants, regardless of necrotizing enterocolitis development. Elife 4. doi: 10.7554/eLife.05477.
140. Frank, J.A., Y. Pan, A. Tooming-Klunderud, et al. 2016. Improved metagenome assemblies and taxonomic binning using long-read circular consensus sequence data. Sci. Rep. 6: 25373.
141. Sangwan, N., F. Xia & J.A. Gilbert. 2016. Recovering complete and draft population genomes from metagenome datasets. Microbiome 4: 8.
142. Kaminski, J., M.K. Gibson, E.A. Franzosa, et al. 2015. High-specificity targeted functional profiling in microbial communities with shortBRED. PLoS Comput. Biol. 11: e1004557.
143. Owen, J.G., Z. Charlop-Powers, A.G. Smith, et al. 2015. Multiplexed metagenome mining using short DNA sequence tags facilitates targeted discovery of epoxyketone proteasome inhibitors. Proc. Natl. Acad. Sci. U.S.A. 112: 4221–4226.
144. Reddy, B.V., A. Milshteyn, Z. Charlop-Powers, et al. 2014. eSNaPD: a versatile, web-based bioinformatics platform for surveying and mining natural product biosynthetic diversity from metagenomes. Chem. Biol. 21: 1023–1033.
145. Reddy, B.V., D. Kallifidas, J.H. Kim, et al. 2012. Natural product biosynthetic gene diversity in geographically distinct soil microbiomes. Appl. Environ. Microbiol. 78: 3744–3752.
146. Eid, J., A. Fehr, J. Gray, et al. 2009. Real-time DNA sequencing from single polymerase molecules. Science 323: 133–138.
147. Tsai, Y.C., S. Conlan, C. Deming, et al. 2016. Resolving the complexity of human skin metagenomes using single-molecule sequencing. MBio 7: e01948–e01915.
148. Oppegard, C., P. Rogne, L. Emanuelsen, et al. 2007. The two-peptide class II bacteriocins: structure, production, and mode of action. J. Mol. Microbiol. Biotechnol. 13: 210–219.
149. Koren, S., G.P. Harhay, T.P. Smith, et al. 2013. Reducing assembly complexity of microbial genomes with single-molecule sequencing. Genome Biol. 14: R101.
150. Gomez-Escribano, J.P., S. Alt & M.J. Bibb. 2016. Next generation sequencing of actinobacteria for the discovery of novel natural products. Mar. Drugs 14. doi: 10.3390/md14040078.
151. Meyer, Q.C., S.G. Burton & D.A. Cowan. 2007. Subtractive hybridization magnetic bead capture: a new technique for the recovery of full-length ORFs from the metagenome. Biotechnol. J. 2: 36–40.
152. Kosuri, S. & G.M. Church. 2014. Large-scale de novo DNA synthesis: technologies and applications. Nat. Methods 11: 499–507.